BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22068114)

  • 1. Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors.
    Ito Y; Kudo T; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    Endocr J; 2012; 59(2):119-25. PubMed ID: 22068114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.
    Ito Y; Kudo T; Kobayashi K; Miya A; Ichihara K; Miyauchi A
    World J Surg; 2012 Jun; 36(6):1274-8. PubMed ID: 22270990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size.
    Ito Y; Fukushima M; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    Endocr J; 2012; 59(6):457-64. PubMed ID: 22447137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study.
    Ito Y; Miyauchi A; Kihara M; Takamura Y; Kobayashi K; Miya A
    Endocr J; 2012; 59(5):399-405. PubMed ID: 22374240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
    Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
    World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
    Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
    Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma.
    Chen L; Zhu Y; Zheng K; Zhang H; Guo H; Zhang L; Wu K; Kong L; Ruan W; Hu J; Zhang X; Chen X
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1035-1042. PubMed ID: 28204971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years.
    Ito Y; Kihara M; Takamura Y; Kobayashi K; Miya A; Hirokawa M; Miyauchi A
    Endocr J; 2012; 59(7):539-45. PubMed ID: 22472193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma.
    Jung TS; Kim TY; Kim KW; Oh YL; Park DJ; Cho BY; Shong YK; Kim WB; Park YJ; Jung JH; Chung JH
    Endocr J; 2007 Apr; 54(2):265-74. PubMed ID: 17379963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up.
    Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
    Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
    World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Risk Factors Contributing to Recurrence of Papillary Thyroid Carcinoma in Chinese Patients Who Underwent Total Thyroidectomy.
    Zhang W; Jiao D; Liu B; Sun S
    Med Sci Monit; 2016 Apr; 22():1274-9. PubMed ID: 27084873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.
    Ito Y; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    World J Surg; 2007 Nov; 31(11):2085-91. PubMed ID: 17885787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
    Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
    J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
    Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
    Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.